Latest Cuba Medical News:
All You Need to Know About Cuba's Lung Cancer Vaccine CIMAVAX-EGF.
Will It Soon Be Available to Everyone in the U.S.?
New heart protector developed in Cuba
Cuban scientists work on 422 research projects aimed at the prevention and treatment of cancer, cardiovascular and neurodegenerative diseases. One of them called CIGB- 500 and promoted by the Center for Genetic Engineering and Biotechnology is currently in clinical trials stage. This cardio-protective product is able to reduce the size of the infarcted area by 78.9 percent in acute myocardial infarction, which proves its worth considering that cardiovascular diseases are the leading cause of death in Cuba.
Novel Cuban VSSP Vaccine in Advanced Breast, Lung, Colon, Prostate Cancer and Leukemia. Superior Efficacy and Safety
VSSP triggers an immune response against a tumor antigen present in malignant cells, meaning that the medication could one day be used to treat leukemia, as well as lung, breast, prostate, and colon cancer. While VSSP, which was originally designed as a composite to boost patients' immune system, also shows signs of stimulating the body's immune response against cancer. NGcGM3 ganglioside is a tumor-specific antigen expressed in human breast tumors. The VSSP vaccine, consisting in very small-sized proteoliposomes (VSSP) obtained by the incorporation of NGcGM3 into the outer membrane protein complex of Neisseria meningitidis, has been tested in a Phase II trial in patients with metastatic breast cancer (MBC). A marked improvement was recorded in patients presenting visceral metastases. While VSSP is still under early clinical trials in Cuba and is not as fully developed as CimaVax, but it appears to have great potential already revealed by the New York-based Roswell Park Cancer Institute which is preparing to test Cuban VSSP for three trials — two in kidney cancer and one in breast cancer.
Heberprot-p unique drug to avoid diabetic amputations soon available in the United Sates
Cuban state run enterprise BioCubaPharma and one of U.S. pharma companies have agreed to work together to make Heberprot-P – a Cuban developed medication to treat diabetic foot ulcers - available to patients in the U.S., once it has been approved by the country's Food and Drug Administration (FDA).
Given the success of the product and following the Memorandum of Understanding signed by the United States Department of Health and Human Services the United States Department of Treasury, Office of Foreign Assets Controls, authorized mentioned U.S. company to enter into agreements with the Cuban party, to conduct all transactions necessary to import Heberprot-P to conduct independent clinical trials authorized by the U.S. Food and Drug Administration (FDA).
Almost one million U.S. citizens are diagnosed with diabetic foot ulcers (DFUs) ever year; a condition which increases the risk of lower-limb amputations. In just five years the number of people suffering from this condition in the U.S. has risen from 73,000 to 85,000, with a significant economic and social impact on the patient, their family members and healthcare system.
Novel neuro-protector to combat Alzheimer's developed in Cuba
Patients displaying early signs of Alzheimer's will be administered NeuroEpo, a Cuban developed product which has demonstrated neuro-protector qualities in experimental phases. This will be the first time the treatment is used with people and we'll have to wait for the results. The medication doesn't prevent or cure Alzheimer's, however the pre-clinical results are encouraging insomuch as it could help to change the course of the disease, that is to say, it could delay its progression. What Cuban doctors want is to slow down the degenerative process, and improve patients' quality of life.
People living with dementia and their caregivers have the same right to get respect, inclusion, diagnosis, quality care and treatment. According to international reports, Alzheimer's disease accounts for 50 to 60% of dementia cases in the world; and every three seconds, someone develops this condition and the number of people is expected to double every 20 years, and by 2050 it will total 152 million. Recognized as one of the most significant health crises of the 21st century, dementia is a collective name for progressive brain syndromes that cause the deterioration over time of a variety of different brain functions. They are memory, thought, recognition, language, planning and personality
New skin cancer drug now available nationwide
Heberferon, the only Cuban drug of its kind in the world for treatment of basal cell carcinoma of skin, is already available throughout the national territory, barely six months after beginning of the program for its extension. During that period, more than 450 patients in Cuba have benefited from the drug which combines the action of two interferons to inhibit tumor growth and eliminate or reduce lesions, including those that are complex, multiple and in advanced stages or are difficult to surgically access, such as the inner corner of the eye, nasal passages, and others on the face.
New Cuban Pneumococcal vaccine to be released next year
A new and effective Pneumococcal vaccine developed by the Finlay Institute, with conjugates against seven most common serotypes, will be available next year. The vaccine registered under the trademark Quimi-Vio will be available nationwide. Pneumococcal is the main cause of pneumonia and meningitis in infants. Although medicines to protect against this disease are available worldwide, Cuba has not been able to access them due to their high cost. After the effectiveness and safety of the vaccine have been established in extensive preclinical studies, clinical trials on humans began in 2014, where over 5,000 children between one and five years of age have been immunized. Quimi-Vio will therefore be added to Cuba's catalogue of infant vaccines, which already features 10 inoculations against 13 diseases, including diphtheria, mumps, measles, rubella and whooping cough, some of which are produced on the island, such as those against Tuberculosis, Hepatitis B and the pentavalent vaccine.
Finding the Right Doctor in Cuba Self-Pay Patients Guide
As Cuba has been in the news recently, some wonder if Cuba has become any closer to being a viable medical travel destination for those who have health issues that require special attention. As a matter of fact Cuba has long been known for producing quality doctors and providing excellent medical services.
Cuban scientists are engaged in late-stage clinical trials in Europe for Heberprot-P, considered a potentially revolutionary medicine for diabetic foot ulcers. Other sectors in which Cuba can use its potential as a "medical power" are lung cancer treatment, cornea, kidney and bone marrow transplants and brain tissue transplants for Parkinson's disease patients.
At Havana's clinics, reserved for foreigners, they handle all types of medical specialties. And if an in-house expert is unavailable, one can be borrowed from another hospital.
Advanced lung cancer treatment, prostate cancer treatment, drug rehab, post-accident and cerebral palsy motor skills rehabilitation, treatment for eye diseases and plastic surgery -- foreign patients can get all of these services and more in Cuba, and at competitive prices.
Heart surgeons in Cuba are doing very complex open heart surgery procedures such as on-pump and off-pump coronary artery bypass grafting (CABG) procedures including complete arterial revascularization. Their outcomes are excellent.
Breast augmentation surgery in Havana costs $1,248 (940 euros), compared to around $6,000 in the United States, $4,350 in Britain and $2,500 in Mexico. On any given day there are 2,000 patients at the largest one of reserved for foreigners Havana clinic from around the world.
Use of stem cells results in Cuba are also encouraging. Stem cells therapy is used in complex fractures, bone cysts, aseptic necrosis of the hip, Arthritis injury joint degenerative, particularly of the knee, periodontitis, heart attacks, paraplegia due to injuries of the spine and spinal cord injury, and in children and adolescents with Muscular Dystrophy Duchenne (DMD).
Most come from Latin America, but there are also patients from places like Angola, Canada, Spain, and even Cuban-Americans from the US. Canadians, or Americans pretending to be Canadians are a target market for eye surgery, dentistry, cosmetic surgery, medical check-ups, drug and alcohol addiction rehabilitation, diabetic foot ulcer treatment and orthopedics. Health tourists are offered top level care at prices that are often far below those in North America. While it is not legal for Americans to go to Cuba as medical tourists, it is legal in Cuba for clinics to deal with Americans; so some Americans either ignore the ban and hope to avoid the fines, or travel from Canada or Mexico.
Among the portfolio of medical programs offered in Cuba one of the most popular is that of quality of life, focused on the prevention and early detection of disease, promoting healthy lifestyles, well-designed and directed toward reducing risk factors for chronic, non-infectious illnesses. Unique Cuban treatments for skin diseases, vitiligo, psoriasis and hair transplantation, glaucoma and retinitis pigmentosa, diabetes treatment, lung cancer, brain cancer, breast cancer, prostate cancer, neurological rehabilitation Parkinson's disease treatment, Alzheimer, nervous system disorders, orthopedics, traumatology, plastic surgery, hepatitis B and C treatment in Cuba are luring thousands of patients from all over the world to Havana as Cuba establishes itself as a top medical center for the whole world.